Manufacturers Life Insurance Company, The Acumen Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 52,333 shares of ABOS stock, worth $91,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,333
Previous 59,996
12.77%
Holding current value
$91,582
Previous $145,000
11.03%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ABOS
# of Institutions
78Shares Held
41.8MCall Options Held
57.7KPut Options Held
749K-
Ra Capital Management, L.P. Boston, MA14.9MShares$26.1 Million0.52% of portfolio
-
Franklin Resources Inc San Mateo, CA3.55MShares$6.21 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$5.98 Million4.37% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$4.03 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.78 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $70.9M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...